The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Shan Q, Yin L, Zhan Q, Yu J, Pan S, Zhuo J, Zhou W, Bao J, Zhang L, Hong J, Xiang J, Que Q, Chen K, Xu S, Wang J, Zhu Y, He B, Wu J, Xie H, Zheng S, Feng T, Ling S, Xu X.
Shan Q, et al. Among authors: pan s.
Signal Transduct Target Ther. 2024 Sep 19;9(1):249. doi: 10.1038/s41392-024-01963-5.
Signal Transduct Target Ther. 2024.
PMID: 39300073
Free PMC article.